Activation of liver X receptor sensitizes human dendritic cells to inflammatory stimuli

Journal of Immunology

Volumn 184, Issue 10, 2010, Pages 5456-5465

  Töröcsik, Dániel ^a   Baráth, Mónika ^a   Benko, Szilvia ^a   Széles, Lajos ^a   Dezso, Balázs ^a   Póliska, Szilárd ^a   Hegyi, Zoltán ^b   Homolya, László ^b   Szatmári, István ^a   Lányi, Árpád ^a   Nagy, László ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; LIVER X RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CYTOKINE; ISOPROTEIN; ORPHAN NUCLEAR RECEPTOR;

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LYMPH NODE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; IMMUNOLOGY; LIPID METABOLISM; METABOLISM; MONOCYTE; PATHOLOGY; PHYSIOLOGY; UPREGULATION;

CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; HUMANS; INFLAMMATION MEDIATORS; LIPID METABOLISM; LYMPH NODES; MONOCYTES; NF-KAPPA B; ORPHAN NUCLEAR RECEPTORS; PROTEIN ISOFORMS; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 77954697899     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902399     Document Type: Article

References (43)

1. Steinman, R. M., G. Kaplan, M. D. Witmer, and Z. A. Cohn. 1979. Identification of a novel cell type in peripheral lymphoid organs of mice. V. Purification of spleen dendritic cells, new surface markers, and maintenance in vitro. J. Exp. Med. 149: 1-16.
2. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
3. Mellman, I., and R. M. Steinman. 2001. Dendritic cells: specialized and regulated antigen processing machines. Cell 106: 255-258. (Pubitemid 32772607)
4. Geissmann, F., P. Revy, N. Brousse, Y. Lepelletier, C. Folli, A. Durandy, P. Chambon, and M. Dy. 2003. Retinoids regulate survival and antigen presentation by immature dendritic cells. J. Exp. Med. 198: 623-634.
5. Nencioni, A., F. Grünebach, A. Zobywlaski, C. Denzlinger, W. Brugger, and P. Brossart. 2002. Dendritic cell immunogenicity is regulated by peroxisome proliferator-activated receptor gamma. J. Immunol. 169: 1228-1235.
6. Penna, G., and L. Adorini. 2000. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 164: 2405-2411. (Pubitemid 30115468)
7. Piemonti, L., P. Monti, P. Allavena, M. Sironi, L. Soldini, B. E. Leone, C. Socci, and V. Di Carlo. 1999. Glucocorticoids affect human dendritic cell differentiation and maturation. J. Immunol. 162: 6473-6481.
8. Piemonti, L., P. Monti, M. Sironi, P. Fraticelli, B. E. Leone, E. Dal Cin, P. Allavena, and V. Di Carlo. 2000. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J. Immunol. 164: 4443-4451.
9. Szatmari, I., P. Gogolak, J. S. Im, B. Dezso, E. Rajnavolgyi, and L. Nagy. 2004. Activation of PPARgamma specifies a dendritic cell subtype capable of enhanced induction of iNKT cell expansion. Immunity 21: 95-106.
10. Szatmari, I., and L. Nagy. 2008. Nuclear receptor signalling in dendritic cells connects lipids, the genome and immune function. EMBO J. 27: 2353-2362.
11. Szatmari, I., D. Töröcsik, M. Agostini, T. Nagy, M. Gurnell, E. Barta, K. Chatterjee, and L. Nagy. 2007. PPARgamma regulates the function of human dendritic cells primarily by altering lipid metabolism. Blood 110: 3271-3280.
12. Széles, L., G. Keresztes, D. Töröcsik, Z. Balajthy, L. Krenács, S. Pó liska, A. Steinmeyer, U. Zuegel, M. Pruenster, A. Rot, and L. Nagy. 2009. 1,25-dihydroxyvitamin D3 is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype. J. Immunol. 182: 2074-2083.
13. Appel, S., V. Mirakaj, A. Bringmann, M. M. Weck, F. Grünebach, and P. Brossart. 2005. PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways. Blood 106: 3888-3894. (Pubitemid 41739028)
14. Song, C., J. M. Kokontis, R. A. Hiipakka, and S. Liao. 1994. Ubiquitous receptor: a receptor that modulates gene activation by retinoic acid and thyroid hormone receptors. Proc. Natl. Acad. Sci. USA 91: 10809-10813.
15. Janowski, B. A., P. J. Willy, T. R. Devi, J. R. Falck, and D. J. Mangelsdorf. 1996. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 383: 728-731.
16. Willy, P. J., K. Umesono, E. S. Ong, R. M. Evans, R. A. Heyman, and D. J. Mangelsdorf. 1995. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev. 9: 1033-1045.
17. Song, C., R. A. Hiipakka, J. M. Kokontis, and S. Liao. 1995. Ubiquitous receptor: structures, immunocytochemical localization, and modulation of gene activation by receptors for retinoic acids and thyroid hormones. Ann. N. Y. Acad. Sci. 761: 38-49.
18. Joseph, S. B., M. N. Bradley, A. Castrillo, K. W. Bruhn, P. A. Mak, L. Pei, J. Hogenesch, R. M. O'connell, G. Cheng, E. Saez, et al. 2004. LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 119: 299-309.
19. Geyeregger, R., M. Zeyda, W. Bauer, E. Kriehuber, M. D. Säemann, G. J. Zlabinger, D. Maurer, and T. M. Stulnig. 2007. Liver X receptors regulate dendritic cell phenotype and function through blocked induction of the actin-bundling protein fascin. Blood 109: 4288-4295.
20. Bensinger, S. J., M. N. Bradley, S. B. Joseph, N. Zelcer, E. M. Janssen, M. A. Hausner, R. Shih, J. S. Parks, P. A. Edwards, B. D. Jamieson, and P. Tontonoz. 2008. LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell 134: 97-111.
21. Joseph, S. B., E. McKilligin, L. Pei, M. A. Watson, A. R. Collins, B. A. Laffitte, M. Chen, G. Noh, J. Goodman, G. N. Hagger, et al. 2002. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc. Natl. Acad. Sci. USA 99: 7604-7609.
22. Castrillo, A., S. B. Joseph, C. Marathe, D. J. Mangelsdorf, and P. Tontonoz. 2003. Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages. J. Biol. Chem. 278: 10443-10449.
23. Levin, N., E. D. Bischoff, C. L. Daige, D. Thomas, C. T. Vu, R. A. Heyman, R. K. Tangirala, and I. G. Schulman. 2005. Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists. Arterioscler. Thromb. Vasc. Biol. 25: 135-142.
24. Castrillo, A., S. B. Joseph, S. A. Vaidya, M. Haberland, A. M. Fogelman, G. Cheng, and P. Tontonoz. 2003. Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol. Cell 12: 805-816.
25. Arai, S., J. M. Shelton, M. Chen, M. N. Bradley, A. Castrillo, A. L. Bookout, P. A. Mak, P. A. Edwards, D. J. Mangelsdorf, P. Tontonoz, and T. Miyazaki. 2005. A role for the apoptosis inhibitory factor AIM/Spalpha/Api6 in atherosclerosis development. Cell Metab. 1: 201-213.
26. Torocsik, D., A. Szanto, and L. Nagy. 2009. Oxysterol signaling links cholesterol metabolism and inflammation via the liver X receptor in macrophages. Mol. Aspects Med. 30: 134-152.
27. Seres, L., J. Cserepes, N. B. Elkind, D. Törocsik, L. Nagy, B. Sarkadi, and L. Homolya. 2008. Functional ABCG1 expression induces apoptosis in macrophages and other cell types. Biochim. Biophys. Acta 1778: 2378-2387.
28. Whitney, K. D., M. A. Watson, B. Goodwin, C. M. Galardi, J. M. Maglich, J. G. Wilson, T. M. Willson, J. L. Collins, and S. A. Kliewer. 2001. Liver X receptor (LXR) regulation of the LXRalpha gene in human macrophages. J. Biol. Chem. 276: 43509-43515.
29. Lehmann, J. M., S. A. Kliewer, L. B. Moore, T. A. Smith-Oliver, B. B. Oliver, J. L. Su, S. S. Sundseth, D. A. Winegar, D. E. Blanchard, T. A. Spencer, and T. M. Willson. 1997. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. Biol. Chem. 272: 3137-3140.
30. Costet, P., Y. Luo, N. Wang, and A. R. Tall. 2000. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J. Biol. Chem. 275: 28240-28245.
31. Schwartz, K., R. M. Lawn, and D. P. Wade. 2000. ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR. Biochem. Biophys. Res. Commun. 274: 794-802.
32. Repa, J. J., S. D. Turley, J. A. Lobaccaro, J. Medina, L. Li, K. Lustig, B. Shan, R. A. Heyman, J. M. Dietschy, and D. J. Mangelsdorf. 2000. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289: 1524-1529.
33. Venkateswaran, A., J. J. Repa, J. M. Lobaccaro, A. Bronson, D. J. Mangelsdorf, and P. A. Edwards. 2000. Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols. J. Biol. Chem. 275: 14700-14707.
34. Kennedy, M. A., A. Venkateswaran, P. T. Tarr, I. Xenarios, J. Kudoh, N. Shimizu, and P. A. Edwards. 2001. Characterization of the human ABCG1 gene: liver X receptor activates an internal promoter that produces a novel transcript encoding an alternative form of the protein. J. Biol. Chem. 276: 39438-39447.
35. Sabol, S. L., H. B. Brewer, Jr., and S. Santamarina-Fojo. 2005. The human ABCG1 gene: identification of LXR response elements that modulate expression in macrophages and liver. J. Lipid Res. 46: 2151-2167.
36. Joseph, S. B., A. Castrillo, B. A. Laffitte, D. J. Mangelsdorf, and P. Tontonoz. 2003. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 9: 213-219.
37. Korf, H., S. Vander Beken, M. Romano, K. R. Steffensen, B. Stijlemans, J. A. Gustafsson, J. Grooten, and K. Huygen. 2009. Liver X receptors contribute to the protective immune response against Mycobacterium tuberculosis in mice. J. Clin. Invest. 119: 1626-1637.
38. Fontaine, C., E. Rigamonti, A. Nohara, P. Gervois, E. Teissier, J. C. Fruchart, B. Staels, and G. Chinetti-Gbaguidi. 2007. Liver X receptor activation potentiates the lipopolysaccharide response in human macrophages. Circ. Res. 101: 40-49.
39. Villablanca, E. J., L. Raccosta, D. Zhou, R. Fontana, D. Maggioni, A. Negro, F. Sanvito, M. Ponzoni, B. Valentinis, M. Bregni, et al. 2010. Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses. Nat. Med. 16: 98-105.
40. Iwasaki, A., and R. Medzhitov. 2004. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5: 987-995.
41. Reis e Sousa, C. 2004. Toll-like receptors and dendritic cells: for whom the bug tolls. Semin. Immunol. 16: 27-34.
42. Traenckner, E. B., H. L. Pahl, T. Henkel, K. N. Schmidt, S. Wilk, and P. A. Baeuerle. 1995. Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J. 14: 2876-2883.
43. Rigamonti, E., G. Chinetti-Gbaguidi, and B. Staels. 2008. Regulation of macrophage functions by PPAR-alpha, PPAR-gamma, and LXRs in mice and men. Arterioscler. Thromb. Vasc. Biol. 28: 1050-1059.